inriver Showcases Innovations and Customer Success at PIMpoint Europe 2023
inriver, the leading software company powering the entire product journey with revenue-driving product information management (PIM) across every customer touchpoint, today unveiled a significant new product innovation and showcased leading brand partners at PIMpoint Europe 2023, its annual conference and the world’s largest product information management event.
This year’s event is highlighted by inriver’s new breed of PIM, an evolution of traditional product information management solutions. As a result of this new breed of PIM, inriver announced continued product innovation to the inriver PIM platform, including ChatGPT functionality to create efficiencies for augmenting product data, and further showcased the power of its now-available syndication capabilities. These innovations have allowed inriver to deliver even more operational efficiency, built-in digital shelf analytics, expanded sales opportunities, and greater sustainability benefits.
“We face unprecedented demand for more sustainability from brands, retailers, and manufacturers as a result of our increasingly circular economy. PIMpoint Europe 2023 comes at such a pivotal moment for our community,” said Niels Stenfeldt, inriver CEO. “As the world prepares for the European Union’s new Digital Product Passport initiative, the new breed of PIM turns global demands for supply chain transparency into new growth drivers for manufacturing companies. There is no better time to welcome our peers across so many industries for meaningful conversations for the future.”
Joining inriver are customer and partner showcases led by leading brands such as Michelin, Victorinox, Öob, Fluidra and more. These brands represent world-class PIM users that inriver helps create, enrich, and syndicate product information across a variety of channels and marketplaces.
Another brand, and inriver customer appearing at PIMpoint is Lantmännen, Northern Europe’s leader in agriculture, machinery, bioenergy and food products. Owned by 18,000 Swedish farmers and with 10,000 employees, Lantmännen has operations in over 20 countries and an annual revenue of approximately SEK 60 billion.
“Lantmännen has a long-term approach to farming, taking an active role in creating more sustainable energy and food supply. We take responsibility from field to fork and focus on issues that are of importance for sustainable, profitable, and thriving farming,” said Håkan Jägbrink, Platform Manager for the IT Commercial Backbone at Lantmännen. “As we are building a sustainable value chain across multiple companies and industries, Lantmännen requires our product data to be complete and accurate. The inriver PIM solution allows us to connect the data across people, processes, and our metadata structure for our 7 different companies. The inriver PIM’s flexible, elastic data model powers our product journey to drive efficiencies and cost reductons. Further, inriver is developing in exactly the right direction for our upcoming requirements.”
In addition to product innovations, brand, and partner showcases, inriver also announced the recipients of the 2022 inriver awards. The awards highlight organizations and individuals leading the industry and driving change in digital commerce and product information management. PIMpoint Europe Award winners:
- 2022 Alliance Ambassador of the Year, Global — Salesforce
- 2022 Alliance Partner of the Year, Global — Bynder
- 2022 Customer of the Year, EMEA — Fluidra
- 2022 Customer Ambassador of the Year, EMEA — Christopher Klumpp, Victorinox
- 2022 Partner of the Year, EMEA — Nexer
- 2022 Partner Project of the Year, EMEA — Nexer for Lantmännen
- 2022 Community Ambassador of the Year, Global — Mark Stuart-Walker, Luceco plc
“This has been a truly awe-inspiring year for the PIM community and the recipients of the 2022 inriver awards are not only being recognized for industry-leading PIM use cases, projects, and innovation but for their dedication to collaboration and business transformation,” said Brooke Cunningham, Chief Marketing Officer, inriver. “This year’s winning customers are leading from the front with their product information strategies, and these partners are committed to helping our joint customers power their entire product journeys. On behalf of the inriver leadership team, I want to thank each and every award recipient for their contribution to driving successful business outcomes.”
PIMpoint is made possible by the inriver valued partner ecosystem and the role it plays in delivering impactful customer stories, including the PIMpoint 2023 Global sponsors Optimizely and Nexer, as well as Europe sponsors Bynder, Delaware, Digizuite, Lengoo, Transperfect, Aprimo, Diamir Consulting, FotoWare, Geta, Immeo, Tietoevry, Etac, Avensia, ChannelEngine, Cypoint Inspire AB, Mad Max Consulting, Priint, and Xsarus.
In addition to customer and partner momentum in the Nordics market, inriver continues to invest in leadership and talent to support its local workforce. Ulrica Falkenberg has recently been appointed as Chief People and Culture Officer for the company based in Stockholm. An accomplished executive and Swedish national, Falkenberg most recently served as CHRO at Trustly, a digital payments company, and has served as an executive at Alumni Harvey Nash, an Executive Talent firm, as well as Max Mara Fashion Group.
About inriver
inriver powers the entire product journey at every touchpoint. The inriver configurable PIM solution, with built-in digital shelf analytics and integration capabilities, connects to your digital ecosystem with flexibility and ease, so it grows as your company grows. With more demands on product data than ever before, B2B and B2C enterprises need a PIM solution that supports the entire product cycle, from sourcing to decommissioning and every stage in between.
inriver helps brands, manufacturers, and retailers turn product information into strategic assets, maximizing profitability at every touchpoint for 1,600+ global brands. Headquartered in Malmö, Sweden, and with offices worldwide, inriver has a team of over 375 people ready to strengthen your product journey. For more information, visit inriver.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230508005195/en/
Contact information
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA ™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 14:00:00 EEST | Press release
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the durable benefit that vimseltinib can offer patients.” Summary of Data and Findings from the 2-year results of the MOTION Phase
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 17:09:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 17:00:00 EEST | Press release
Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 16:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B cell-mediated diseases. Pove is the only BAFF+APRIL inhibitor in pivotal trials for multiple kidney diseases. Next Steps for Pove Development In IgAN Following the announcement that the Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) to pove for the treatment of IgAN, FDA recently granted a rolling review of the Biologics License Application (BLA) for pove for this indication. Vertex expects to submit the first module to FDA for potential accelerated approval before t
Qualcomm Announces Quarterly Cash Dividend17.10.2025 16:00:00 EEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom